Insight Molecular Diagnostics Inc. · NASDAQ:IMDX
Broadwood Partners, L.P. reported a 37.40% stake in Insight Molecular Diagnostics Inc. (Schedule 13D/A)
Event Feb 10, 2026 · Filed Feb 12, 2026
Broadwood Partners, L.P. reported a 37.40% stake in Insight Molecular Diagnostics Inc., 12,081,932 shares, with active intent on Feb 10, 2026. Filed Feb 12, 2026 (Schedule 13D/A).
- Stake
- 37.40%
- Shares
- 12,081,932
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Broadwood Partners, L.P. | 37.40% | 12,081,932 |
| Broadwood Capital, Inc. | 37.40% | 12,081,932 |
| Neal C. Bradsher | 37.40% | 12,082,089 |
Source
Related
- Insight Molecular Diagnostics Inc.
- Broadwood Partners, L.P.
- Insight Molecular Diagnostics Inc. shareholders
- Schedule 13D/A · Broadwood Partners, L.P. · Apr 27, 2026
- Schedule 13D/A · Broadwood Partners, L.P. · Feb 10, 2025
- Form 4 · Silverman Lou · Jul 6, 2026
- Form 4 · Last Andrew J. · Jul 6, 2026
- Form 4 · Arno Andrew · Jul 6, 2026
- Form 4 · Silverman Lou · Jun 15, 2026
- Form 4 · Last Andrew J. · Jun 15, 2026